JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305387200 on June 25, 2003

J. Biol. Chem., Vol. 278, Issue 37, 35421-35427, September 12, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/37/35421    most recent
M305387200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shingai, T.
Right arrow Articles by Takai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shingai, T.
Right arrow Articles by Takai, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in Epithelial Cells*

Tatsushi Shingai {ddagger} §, Wataru Ikeda {ddagger}, Shigeki Kakunaga {ddagger}, Koji Morimoto ¶, Kyoji Takekuni {ddagger} §, Shinsuke Itoh {ddagger}, Keiko Satoh ¶, Masakazu Takeuchi ¶, Toshio Imai ¶, Morito Monden § and Yoshimi Takai {ddagger} ||

From the {ddagger}Department of Molecular Biology and Biochemistry and §Department of Surgery and Clinical Oncology, Osaka University Graduate School of Medicine/Faculty of Medicine, Suita 565-0871, Osaka, Japan and KAN Research Institute Inc., 93 Chudoji-Awatamachi, Shimogyo-ku, Kyoto 600-8815, Japan

Received for publication, May 22, 2003 , and in revised form, June 13, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Nectins are Ca2+-independent immunoglobulin-like cell-cell adhesion molecules that play roles in organization of a variety of cell-cell junctions in cooperation with or independently of cadherins. Four nectins have been identified. Five nectin-like molecules, which have domain structures similar to those of nectins, have been identified, and we characterized here nectin-like molecule-2 (Necl-2)/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1. Necl-2 showed Ca2+-independent homophilic cell-cell adhesion activity. It furthermore showed Ca2+-independent heterophilic cell-cell adhesion activity with Necl-1/TSLL1/SynCAM3 and nectin-3. Necl-2 was widely expressed in rat tissues examined. Necl-2 localized at the basolateral plasma membrane in epithelial cells of the mouse gall bladder, but not at specialized cell-cell junctions, such as tight junctions, adherens junctions, and desmosomes. Nectins bind afadin, whereas Necl-2 did not bind afadin but bound Pals2, a membrane-associated guanylate kinase family member known to bind Lin-7, implicated in the proper localization of the Let-23 protein in Caenorhabditis elegans, the homologue of mammalian epidermal growth factor receptor. These results indicate the unique localization of Necl-2 and its possible involvement in localization of a transmembrane protein(s) through Pals2.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell-cell adhesion is critical for tissue patterning and morphogenesis as well as for maintenance of normal tissues. In polarized epithelial cells, intercellular adhesion is mediated through a junctional complex comprised of tight junctions (TJs),1 adherens junctions (AJs), and desmosomes (DSs) (1). These junctional structures are typically aligned from the apical to basal sides, although DSs are independently distributed in other areas. The formation and maintenance of TJs and DSs depend upon the formation and maintenance of AJs. At TJs, claudins are key cell-cell adhesion molecules that form TJ strands (1). At AJs, E-cadherin is a key Ca2+-dependent cell-cell adhesion molecule (2, 3). TJs and AJs are undercoated with actin filament (F-actin) bundles. At DSs, desmosomal cadherins, desmocollin and desmoglein, are key Ca2+-dependent cell-cell adhesion molecules (4). DSs are linkers of the intermediate filament cytoskeleton.

Nectins are emerging cell-cell adhesion molecules that play roles in the organization of a variety of cell-cell junctions, such as AJs and TJs in epithelial cells, synaptic junctions in neurons, and heterotypic junctions formed between the Sertoli cells and spermatids in the testis, in cooperation with or independently of cadherins (5). Although cadherins are Ca2+-dependent cell-cell adhesion molecules, nectins are Ca2+-independent cell-cell adhesion molecules that comprise a family of four members, nectin-1, -2, -3, and -4 (5). All nectins have one extracellular region with three Ig-like loops, one transmembrane region, and one cytoplasmic region (5). Each nectin forms homo-cis-dimers followed by formation of homo-trans-dimers, causing cell-cell adhesion (5). Nectin-3 furthermore forms hetero-trans-dimers with either nectin-1 or -2, and the adhesion activity of each hetero-trans-dimers is stronger than that of each homo-trans-dimers (5). Nectin-4 also forms hetero-trans-dimers with nectin-1 (5). Nectins except nectin-4 have a C-terminal conserved motif of four amino acid (aa) residues that interacts with the PDZ domain of afadin (5). Nectin-4 does not have this consensus motif but binds afadin. Afadin is an F-actin-binding protein with one PDZ domain and three other domains and connects nectins to the actin cytoskeleton (5).

Five molecules with one extracellular region containing three Ig-like loops, one transmembrane region, and one cytoplasmic region have thus far been identified. We have proposed, based on their domain structures which are similar to those of nectins, that these molecules are called nectin-like molecules (Necls) (6). These include Necl-1/TSLL1/SynCAM3 (7, 8), Necl-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 (812), Necl-3/similar to Necl-3/SynCAM2 (8), Necl-4/TSLL2/Syn-CAM4 (7, 8), and Necl-5/Tage4/PVR/CD155 (6, 1316). Of these, we focus here on Necl-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1. Necl-2 was directly submitted to GenBankTM (GenBankTM/EMBL/DDBJ accession number AF061260 [GenBank] (1998); GenBankTM/EMBL/DDBJ accession number AF132811 [GenBank] (1999)); IGSF4 was identified as a candidate for a tumor suppressor gene associated with loss of heterozygosity of chromosome 11q23.2 (9); RA175 was identified to be a gene highly expressed during neuronal differentiation of embryonic carcinoma cells (10); SgIGSF was identified to be a gene expressed in spermatogenic cells during earlier stages of spermatogenesis (11); and TSLC1 was identified to be a tumor suppressor in human non-small cell lung cancer (12). TSLC1 shows Ca2+-independent homophilic cell-cell adhesion activity (17). TSLC1 has a band 4.1-binding motif at the juxtamembrane region and binds tumor suppressor DAL-1, one of the band 4.1 family members, which connects TSLC1 to the actin cytoskeleton (18); SynCAM1 was identified to be a brain-specific synaptic adhesion molecule (8). SynCAM1 shows Ca2+-independent homophilic cell-cell adhesion activity (8). SynCAM1 forms synapses between HEK293 cells expressing exogenous SynCAM1 and primary cultured hippocampal neurons in vitro (8). SynCAM1 has been shown to be specifically expressed in mouse brain as estimated by Western blotting (8), but TSLC1 and SgIGSF have been shown to be expressed ubiquitously as estimated by Northern blotting (11, 19). This molecule with six different nomenclatures is referred to Necl-2.

We have studied the properties of Necl-2, including its cell-cell adhesion activity, its localization, and its binding protein. We have found that Necl-2 localizes at the extra-junctional region of the basolateral plasma membrane of epithelial cells and directly binds Pals2. Pals2 was originally isolated as a Lin-7-binding protein (20). Lin-7 is a PDZ domain-containing protein that forms a heterotrimeric complex with Lin-2 and -10. This Lin-2·Lin-7·Lin-10 protein complex is involved in organization of epithelial and neuronal junctions in Caenorhabditis elegans and mammals (21). Pals2 belongs to the membrane-associated guanylate kinase family and consists of two Lin-2/-7 homology domains, one PDZ domain, one Src-homology 3 domain, and one guanylate kinase domain. Pals2 as well as Pals1 and Lin-2 constitutes a subfamily that binds to Lin-7 (20). Here we describe these novel properties of Necl-2.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Molecular Cloning of Mouse Necl-1 and -2 cDNAs—We performed reverse transcription-PCR from mouse brain total RNA using the Isogen RNA extraction kit (Nippon Gene), Ready-To-Go You-Prime First-Strand Beads and pd(N)6 (Amersham Biosciences), Pfu turbo DNA polymerase (Stratagene), and the specific primers of mouse Necl-1 or -2. The primers were designed based on Necl-1 (GenBankTM/EMBL/DDBJ accession number AF195662 [GenBank] ) and Necl-2 (GenBankTM/EMBL/DDBJ accession number AB052293 [GenBank] ). The forward and reverse primers used were; Necl-1 cDNA, 5'-gcggaattcaccatgggggccccttccgccc-3' and 5'-gcggtcgacctagatgaaatattccttcttgtc-3'; Necl-2 cDNA, 5'-gcggaattcaccatggcgagtgctgtgctgcc-3' and 5'-gcggtcgacctagatgaagtactctttcttttc-3', respectively. The reverse transcription-PCR products were cloned using Zero Blunt TOPO PCR cloning kit (Invitrogen). DNA sequencing was performed by the dideoxy nucleotide termination method using a DNA sequencer (ABI Prism 3100 Genetic Analyzer, PE Biosystems). The Necl-1 cDNA clone that we isolated was identical to AF195662 [GenBank] (data not shown). The Necl-2 cDNA clone that we isolated was identical to AB052293 [GenBank] except for the deletion of 336–363 aa at the extracellular region (data not shown, GenBankTM/EMBL/DDBJ accession number AY351388 [GenBank] ). This deletion has been reported as one of the splicing variants (8).

Construction of Plasmids—Expression vectors were constructed in pFLAG-CMV1 (Sigma), pCAGIPuro (22), pCAGIZeo (23), pGBD-C1 (24), pGEX4T-1 (Amersham Biosciences), pMAL-C2 (New England Biolabs Inc.), pGAD424-HA (25), pFastBac1-Msp-Fc (26), and pCMV-HA (27). Various constructs of Necl-1 and -2 contained the following aa: pFLAG-CMV1-Necl-1, aa 20–396 (deleting the signal peptide); pCAGI-Puro-FLAG-Necl-1, aa 20–396 (including the preprotrypsin signal peptide); pCAGIZeo-Necl-2, aa 1–417 (full-length); pFLAG-CMV1-Necl-2, aa 43–417 (deleting the signal peptide); pCAGIPuro-FLAG-Necl-2, aa 43–417 (including the preprotrypsin signal peptide); pCAGIPuro-Necl-2-{Delta}C, aa 1–413 (deleting the C-terminal 4 aa); pFastBac1-Msp-Fc-Necl-2-EC, aa 43–348 (the extracellular region deleting the signal peptide); pGBD-C1-Necl-2-{Delta}EC, aa 335–417 (deleting the extracellular region); pGEX4T-1-Necl-2-CP, aa 372–417 (the cytoplasmic region); pGEX4T-1-Necl-2-CP{Delta}C, aa 372–413 (the cytoplasmic region deleting the C-terminal 4 aa). The cDNA of mouse Pals2 was kindly provided by Dr. B. Margolis (University of Michigan Medical Center, Ann Arbor, MI). Constructs of mouse Pals2 contained the following aa: pCMV-HA-Pals2, aa 1–539 (full-length); pMAL-C2-Pals2, aa 1–539 (full-length); pMAL-C2-Pals2-PDZ, aa 361–639 (PDZ domain). Various constructs of nectin-2{alpha} and l-afadin contained the following aa: pGEX4T-1-nectin-2{alpha}-CP, aa 387–467 (the cytoplasmic region); pGBD-C1-nectin-2-CP, aa 387–467 (the cytoplasmic region); pMAL-C2-afadin-PDZ, aa 1007–1125 (PDZ domain); and pGAD424-HA-l-afadin, aa 1–1829 (full-length) (25, 28). The IgG Fc fusion proteins were prepared as a secreted protein from the baculovirus transfer system (Invitrogen) and purified by use of protein A-Sepharose beads (Amersham Biosciences) as described (26). The glutathione S-transferase (GST) and maltose-binding protein (MBP) fusion proteins were purified by use of glutathione-Sepharose beads (Amersham Biosciences) and amylose resin beads (New England Biolabs, Inc.), respectively.

Cell Culture and Establishment of Transfectants—L and MTD-1A cells were kindly supplied by Dr. S. Tsukita (Kyoto University, Kyoto, Japan). L and MTD-1A cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. L cell lines stably expressing human nectin-1{alpha}, mouse nectin-2{alpha}, mouse nectin-3{alpha}, or mouse Necl-5 (nectin-1-L, -2-L, -3-L, and Necl-5-L cells, respectively) were prepared as described (6, 22, 28, 29). An L cell line stably expressing FLAG-Necl-1 (Necl-1-L cells), full-length Necl-2 (non-tagged-Necl2-L cells), FLAG-Necl-2 (Necl-2-L cells), or Necl-2-{Delta}C (Necl-2-{Delta}C-L cells) was obtained by transfection with pCAGIPuro-FLAG-Necl-1, pCAGIZeo-Necl-2, pCAGIPuro-FLAG-Necl-2, or pCAGIPuro-Necl-2-{Delta}C, respectively, using LipofectAMINE PLUS reagent (Invitrogen). We mostly used Necl-2-L cells (FLAG-tagged Necl-2) in the present study, but the essentially similar results were obtained with non-tagged Necl-2-L cells.

Antibodies—A rat anti-Necl-2 monoclonal Ab (mAb) (1C4-2) was raised against the fusion protein of the extracellular region of Necl-2 (aa 43–348) with IgG Fc. The anti-Necl-2 mAb was used for both Western blotting and immunostaining. An anti-l-afadin polyclonal antibody (pAb) was prepared as described (30). An anti-FLAG mAb (M1) and pAb were purchased from Sigma. An anti-ZO-1 mAb (AB01003) and pAb (61–7300) were purchased from Sanko Junyaku Co. and Zymed Laboratories Inc., respectively. An anti-HA mAb was purchased from Berkeley Antibody Co.

Yeast Two-hybrid Screening—The yeast two-hybrid library constructed from mouse testis cDNA was purchased from Clontech, and a Necl-2-binding protein(s) was screened using pGBD-C1-Necl-2-{Delta}EC as bait as described (24). Two-hybrid screening using the yeast strain PJ69–4A (MATa trp1–901 leu2-3, 112 ura3-52 his3-200 gal4{Delta} gal80{Delta} GAL2-ADE2 LYS2::GAL1-HIS3 met2::GAL7-lacZ) was done as described (24).

Other Procedures—Immunofluorescence microscopy of cultured cells and co-immunoprecipitation assay were done as described (28). The cell aggregation assay, chemical cross-linking, and affinity chromatography were done as described (29). Immunoelectron microscopy of mouse tissues was done using the silver enhancement technique as described (31). SDS-PAGE was done as described (32). Protein concentrations were determined with bovine serum albumin as a reference protein as described (33).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Ca2+-independent Homophilic Cell-Cell Adhesion Activity of Necl-2—TSLC1 and SynCAM1, which are identical with Necl-2, have been shown to have Ca2+-independent homophilic cell-cell adhesion activity by aggregation assay using Madin-Darby canine kidney (MDCK) cells expressing green fluorescent protein (GFP)-tagged TSLC1 (17) and Drosophila S2 cells expressing SynCAM1 (8). We first confirmed these earlier results by measuring the aggregation activity of Necl-2-L cells (cadherin-deficient L cells stably expressing Necl-2). Wild-type L cells endogenously expressed nectin-1 and -2 (22, 26), but expression of Necl-2 was undetectable by Western blotting (see Fig. 5A). Wild-type L cells did not form visible cell aggregates (Fig. 1, Aa), but Necl-2-L cells formed aggregates (Fig. 1, Ab). The sizes of the aggregates were not significantly affected by the presence of Ca2+ or EDTA (data not shown). These results are consistent with the earlier observation (8, 17) and indicate that Necl-2 has Ca2+-independent homophilic cell-cell adhesion activity. This cell-cell adhesion activity of Necl-2 was furthermore confirmed by immunofluorescence microscopy. When Necl-2-L cells were cultured, the immunofluorescence signal for Necl-2 was concentrated at cell-cell contact sites (Fig. 1B). We have previously shown that each nectin forms cis-dimers followed by formation of trans-dimers, eventually causing cell-cell adhesion (22). Similarly, Necl-2 formed cis-dimers (Fig. 1C). These results are consistent with the earlier observation using HEK293 cells expressing TSLC1 (17). It is likely by analogy with the mode of action of nectins that Necl-2 forms first cis-dimers followed by formation of trans-dimers, eventually causing cell-cell adhesion.



View larger version (76K):
[in this window]
[in a new window]
 
FIG. 5.
Expression of Necl-2 in an epithelial cell line, but not in fibroblast cell lines. A, expression levels of the Necl-2 protein in cell lines. Cell lysates of various cell lines (each 10 µg of protein) were subjected to SDS-PAGE (10% polyacrylamide gel) followed by Western blotting with the anti-Necl-2 mAb. B, localization of Necl-2 in MTD-1A cells. The samples were doubly stained with the anti-Necl-2 mAb and rhodamine-phalloidin. Confocal images of a1, a2, and a3 are the apical side of the images of b1, b2, and b3. a1 and b1, Necl-2; a2 and b2, actin; a3 and b3, merge. Bars, 10 µm. The results shown are representative of three independent experiments.

 


View larger version (124K):
[in this window]
[in a new window]
 
FIG. 1.
Homophilic cell-cell adhesion activity of Necl-2. A, cell aggregation activity of Necl-2. A single-cell suspension was rotated for 10 min. a, wild-type L cells. b, Necl-2-L cells. Bars, 100 µm. B, localization of Necl-2 at cell-cell adhesion sites of Necl-2-L cells. The localization of Necl-2 in Necl-2-L cells was analyzed by immunofluorescence microscopy with the anti-Necl-2 mAb. Bars, 10 µm. C, formation of homo-cis-dimers of Necl-2. A single-cell suspension of Necl-2-L cells was incubated in the presence or absence of bis(sulfosuccinimidyl) suberate (BS3). Each cell lysate (10 µg of protein each) was subjected to SDS-PAGE (10% polyacrylamide gel) followed by Western blotting with the anti-FLAG mAb. Arrow, monomer; arrowhead, dimer; double arrow-head, unknown band detected by the anti-FLAG mAb. The results shown are representative of three independent experiments.

 

Ca2+-independent Heterophilic Cell-Cell Adhesion Activity of Necl-2—Nectins show both homophilic and heterophilic cell-cell adhesion activities (5). We next examined by the cell aggregation assay whether Necl-2 shows heterophilic cell-cell adhesion activity with other nectins and Necls. Necl-2-L cells formed heterophilic cell aggregates with L cells stably expressing Necl-1 or nectin-3 (Necl-1-L and nectin-3-L cells, respectively) but not with L cells stably expressing Necl-5, nectin-1, or nectin-2 (Necl-5-L, nectin-1-L, or -2-L cells, respectively) (Fig. 2, A–E). Necl-1-L cells formed homophilic cell aggregates (Fig. 2F). The sizes of the aggregates were not significantly affected by the presence of Ca2+ or EDTA (data not shown). The detailed properties of Necl-1 will be described elsewhere. Necl-5-L cells did not form homophilic cell aggregates as described (Fig. 2G) (6). Nectin-1-L, -2-L, and -3-L cells formed homophilic cell aggregates as described (Fig. 2, H–J) (28, 29). The size of the cell aggregates formed between nectin-1-L and nectin-3-L cells was the biggest among various combinations (5). The sizes of the cell aggregates formed between Necl-2-L and Necl-2-L cells, between Necl-2-L and Necl-1-L cells, and between Necl-2-L and nectin-3-L cells were about 5, 10, and 10% that of the aggregates formed between nectin-1-L and nectin-3-L cells, respectively. These results indicate that Necl-2 has both Ca2+-independent homophilic and heterophilic cell-cell adhesion activities.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 2.
Heterophilic cell-cell adhesion activity of Necl-2. A single-cell suspension was rotated for 10 min. A–E, heterophilic cell aggregation activity between 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-labeled Necl-2-L cells and various unlabeled L cell lines. A, with Necl-1-L cells; B, with Necl-5-L cells; C, with nectin-1-L cells; D, with nectin-2-L cells; E, with nectin-3-L cells. F–J, homophilic cell aggregation activity of various L cell lines. F, Necl-1-L cells; G, Necl-5-L cells; H, nectin-1-L cells; I, nectin-2-L cells; J, nectin-3-L cells. Bars, 100 µm. The results shown are representative of three independent experiments.

 

Tissue Distribution and Subcellular Localization of Necl-2— TSLC1 has been shown by Northern blotting to be expressed ubiquitously, except the skeletal muscle, in which the expression of TSLC1 was not detected (11, 19). We confirmed these earlier results by Western blotting using the anti-Necl-2 mAb. Western blotting showed that an immunoreactive band at a molecular mass of 92 kDa was detected in various tissues thus far examined, including the brain, the lung, and the kidney (Fig. 3). In the testis, a larger band at 105 kDa was detected and might be one of the alternative splicing variants as described (8). After long exposure, the immunoreactive band of Necl-2 was detected in other tissues including the heart, the spleen, and the liver but was not detected in the skeletal muscle (data not shown). Immunofluorescence microscopy revealed that the signal for Necl-2 was highly concentrated at the basolateral plasma membrane of the epithelial cells of the mouse gall bladder, liver, and pancreas (Fig. 4A, a1, b1, and c1). It may be noted that the signal for Necl-2 was not overlapped with the signal for afadin, which is known to be confined to AJs undercoated with the F-actin bundles (Fig. 4A, a1–a3), nor the signal for ZO-1, which is known to be confined to TJs (Fig. 4A, b1–b3 and c1–c3). Consistently, immunoelectron microscopy showed that the immunogold particles for Necl-2 were indeed concentrated at the basolateral plasma membrane of the epithelial cells of gall bladder, but was undetectable at the areas of TJs, AJs, and DSs (Fig. 4B, a–c). These findings about Necl-2 showed sharp contrast to the localization of nectins and afadin that are strictly confined to AJs, which are undercoated with F-actin bundles (5).



View larger version (64K):
[in this window]
[in a new window]
 
FIG. 3.
Tissue distribution of Necl-2. Homogenates of various mouse tissues (20 µg of protein each) were subjected to SDS-PAGE (10% polyacrylamide gel) followed by Western blotting with the anti-Necl-2 mAb. The results shown are representative of three independent experiments. Sk. muscle, skeletal muscle.

 


View larger version (83K):
[in this window]
[in a new window]
 
FIG. 4.
Subcellular localization of Necl-2. A, immunofluorescence images of various mouse tissues. The frozen sections of mouse gall bladder, liver, and pancreas were doubly stained with various combinations of the anti-Necl-2, anti-l-afadin, and anti-ZO-1 Abs. a, gall bladder; b, liver; c, pancreas. a1, b1, and c1, Necl-2; a2, l-afadin; b2, and c2, ZO-1; a3, b3, and c3, merge. Arrows, the cell-cell junctions of bile canaliculi. Bars, 10 µm. B, immunogold electron microscopic images of mouse gall bladder epithelial cells. The samples were stained with the anti-Necl-2 mAb followed by immunogold electron microscopy with the silver-enhanced immunogold method. a and b, junctional complex region at the apical side of gall bladder epithelial cells; c, basolateral plasma membrane of gall bladder epithelial cells. Bars, 250 nm. The results shown are representative of three independent experiments.

 

Expression of Necl-2 in an Epithelial Cell Line, but Not in Fibroblast Cell Lines—We next examined whether Necl-2 is differentially expressed in cells in culture. Western blotting revealed that Necl-2 was detected in mouse MTD-1A epithelial cells but not in mouse fibroblastic L, NIH3T3, or Swiss3T3 cells (Fig. 5A). The larger protein of 105 kDa detected in MTD-1A cells appeared to be an alternative splicing variant of Necl-2 as detected in the testis. In MTD-1A cells the immunofluorescence signal for Necl-2 was concentrated at the basolateral plasma membrane of cell-cell contact sites (Fig. 5B, a1–a3 and b1–b3). In contrast, the signal for Necl-2 was not observed in L, NIH3T3, or Swiss3T3 cells (data not shown). These results suggest that Necl-2 is dominantly expressed in epithelial cells but not in fibroblasts.

Assembly of Necl-2 to Cell-Cell Junctions at the Initial Stage of Their Formation—We next studied how Necl-2 localizes to the basolateral plasma membrane. The nectin-afadin unit plays a key role in the formation of the junctional complex of AJs and TJs in epithelial cells (5). Wound healing assay using MTD-1A cells have revealed that nectin, afadin, ZO-1, E-cadherin, and {alpha}- and {beta}-catenins are first assembled at the primordial, spot-like adhesion sites including AJs (34, 35). These primordial adhesion sites fuse with each other to form short line-like adhesion sites, which develop into more matured AJs. During and/or after the formation of AJs, junctional adhesion molecule (JAM) is first assembled at these adhesion sites (36). Finally, occludin and claudin are recruited at the apical side of AJs, resulting in the formation of TJs (37, 38). We examined at which stage Necl-2 is recruited to the adhesion sites. The immunofluorescence signal for Necl-2 was detected at the spot-like adhesion sites (Fig. 6, Aa–Ac). The signal was also observed at the line-like adhesion sites (Fig. 6, Ba–Bc), but the sites of the signal for Necl-2 were different from those for ZO-1 and afadin (Fig. 6, Ca-Cc and Da-Dc). These results suggest that Necl-2 is assembled to the cell-cell adhesion sites at the very early stage together with the components of the nectinafadin and E-cadherin-catenin units, and thereafter, is translocated to the other sites, presumably the extra-junctional region of the basolateral plasma membrane.



View larger version (81K):
[in this window]
[in a new window]
 
FIG. 6.
Assembly of Necl-2 to cell-cell junctions at the initial stage of their formation. Confluent cell layers were manually scratched with a needle and cultured for 6 h (spot-like adhesion sites) and for 8 h (line-like adhesion sites) followed by double-staining with various combinations of the anti-Necl-2, anti-l-afadin, and anti-ZO-1 Abs and rhodamine-phalloidin. A, spot-like adhesion sites; B, C, and D, line-like adhesion sites. Aa and Ba, actin; Ca, ZO-1; Da, l-afadin; Ab, Bb, Cb, and Db, Necl-2; Ac, Bc, Cc, and Dc, merge. Arrows, adhesion sites. Bars, 10 µm. The results shown are representative of three independent experiments.

 

Direct Binding of Pals2 to Necl-2—Nectins except nectin-4 have a C-terminal conserved motif of four aa residues that interacts with the PDZ domain of afadin (5). Although Necl-2 has this motif, Necl-2 did not bind afadin, as estimated by the yeast two-hybrid assay and the affinity chromatography assay (Fig. 7, A and D). Therefore, in the last set of experiments we attempted to isolate a Necl-2-binding protein(s). By use of the transmembrane and cytoplasmic region of Necl-2 (Necl-2-{Delta}EC) as bait, we searched a Necl-2-binding protein(s) by the yeast two-hybrid screening and isolated one positive clone from a mouse testis library (Fig. 7A). It encoded Pals2 (lacking the N-terminal 1–31 aa). We then examined whether Necl-2 directly binds Pals2 in vitro and in vivo using the constructs of full-length Pals2. FLAG-tagged Necl-2 and HA-tagged Pals2 were coexpressed in HEK293 cells, and FLAG-tagged Necl-2 was immunoprecipitated with the anti-FLAG mAb. HA-tagged Pals2 was co-immunoprecipitated with FLAG-tagged Necl-2 (Fig. 7B). When HA-tagged Pals2 was overexpressed in Necl-2-L cells, the signal for Pals2 was co-localized with that for Necl-2 at the cell-cell contact sites (Fig. 7C, a1–a3). However, when HA-tagged Pals2 was overexpressed in Necl-2-{Delta}C-L cells (L cells stably expressing the C-terminal four aa-deleted Necl-2), the signal for Necl-2-{Delta}C was concentrated at the cell-cell contact sites, but the signal for Pals2 was not concentrated there (Fig. 7C, b1–b3). The pure recombinant protein of the cytoplasmic region of Necl-2 (GST-Necl-2-CP) bound the pure recombinant protein of full-length Pals2 (MBP-Pals2) (Fig. 7D) and the PDZ domain of Pals2 (MBP-Pals2-PDZ) (data not shown). However, the pure recombinant protein of the cytoplasmic region of Necl-2, of which the C-terminal four aa were deleted (GST-Necl-2-CP{Delta}C), did not bind MBP-Pals2 (Fig. 7D) or MBP-Pals2-PDZ (data not shown). These results indicate that Necl-2 directly binds Pals2 and that this binding is mediated through the C-terminal four aa of Necl-2 and the PDZ domain of Pals2.



View larger version (39K):
[in this window]
[in a new window]
 
FIG. 7.
Direct binding of Pals2 to Necl-2. A, yeast two-hybrid analysis of binding of Necl-2-{Delta}EC to Pals2. Yeast transformants with the indicated plasmids were streaked on synthetic complete medium lacking adenine to score ADE2 reporter activity and incubated at 30 °C for 3 days. pACT2-Pals2 (lacking the N-terminal 1–31 aa) was a positive clone that was isolated by yeast two-hybrid screening of pGBD-C1-Necl-2-{Delta}EC from a mouse testis library. B, co-immunoprecipitation of Pals2 with Necl-2. pFLAG-CMV1-Necl-2 and pCMV-HA-Pals2 (full-length) were transfected to HEK293 cells, and the cell extract (500 µg of protein each) was subjected to immunoprecipitation with the anti-FLAG mAb. The immunoprecipitates were then subjected to SDS-PAGE (10% polyacrylamide gel) followed by Western blotting with the anti-HA mAb or the anti-FLAG pAb. C, Necl-2-dependent recruitment of Pals2 to cell-cell adhesion sites. Necl-2-L or Necl-2-{Delta}C-L cells were transfected with pCMV-HA-Pals2 (full-length) and doubly stained with the anti-HA mAb and the anti-Necl-2 mAb. a, Necl-2-L cells; b, Necl-2-{Delta}C-L cells. a1, Necl-2; b1, Necl-2-{Delta}C; a2 and b2, HA-Pals2; a3 and b3, merge. Asterisks indicate the transfectants expressing HA-tagged Pals2. Bars,10 µm. D, direct binding of Pals2 to Necl-2. GST-Necl-2-CP, GST-Necl-2-CP{Delta}C, or GST-nectin-2-CP (2 nmol of protein each) was applied to amylose resin beads on which MBP-Pals2 (full-length) or MBP-afadin-PDZ (200 pmol of protein each) was immobilized. After the beads were extensively washed, and the bound proteins were subjected to SDS-PAGE (13% polyacrylamide gel) followed by protein staining with Coomassie Brilliant Blue. The molecular masses of the recombinant proteins are: MBP-Pals2, 103 kDa; MBP-afadin-PDZ, 53 kDa; GST-Necl-2-CP, 36 kDa; GST-Necl-2CP{Delta}C, 34 kDa; GST-nectin-2-CP, 39 kDa. Arrowhead, MBP-Pals2; open arrowhead, MBP-afadin-PDZ. The results shown are representative of three independent experiments.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Studies on Necl-2-mediated cell aggregation using MDCK-cells expressing GFP-tagged TSLC1 and Drosophila S2 cells expressing SynCAM1 have shown that Necl-2 has Ca2+-independent homophilic cell-cell adhesion activity (8, 17). We have confirmed here these earlier observations by the aggregation assay using L cells expressing each cell-cell adhesion molecule (17). Then we have shown that Necl-2 has furthermore Ca2+-independent heterophilic cell-cell adhesion activity with Necl-1/TSLL1/SynCAM3 and nectin-3 but not with Necl-5/Tage4/CD155/PVR, nectin-1, or nectin-2, suggesting that Necl-2 is capable of organizing cell-cell adhesion by interactions with these molecules.

TSLC1 and SgIGSF have been shown to be expressed ubiquitously as estimated by Northern blotting (11, 19), but SynCAM1 has been shown to be specifically expressed in the mouse brain, as analyzed by Western blotting (8). Our present result indicates that Necl-2 is expressed in a wide variety of mouse tissues thus far examined and is consistent with the results of TSLC1 and SgIGSF but not with that of SynCAM1 (8). The exact reason for this inconsistency between the result of SynCAM1 and those of TSLC1, SgIGSF, and Necl-2 is not known, but it could be attributed to the specificity of the Ab used for SynCAM1.

Immunofluorescence microscopic analysis indicates that Necl-2 localizes at the basolateral plasma membrane of many epithelial cell types, and this result is consistent with the earlier observation that TSLC1 localizes at the basolateral plasma membrane of MDCK cells expressing GFP-tagged TSLC1 (17). Detailed analysis by immunoelectron microscopy indicates that Necl-2 localizes at the basolateral plasma membrane except for specialized cell-cell junctions, such as AJs, TJs, and DSs. This unique localization pattern of Necl-2 is quite different from those of any other known cell-cell adhesion molecules: claudins, occludin, and JAM at TJs, nectins at AJs, E-cadherin at AJs and the lateral plasma membrane, and desmocollin and desmoglein at DSs (1, 4, 5, 39, 40).

Nectin-3 has been shown to be involved in the formation of AJs in epithelial cells (5). Therefore, the ability of Necl-2 to interact with nectin-3 suggests that Necl-2 may be recruited to the nectin-3-based cell-cell adhesion in the process of forming AJs. Consistently, wound healing assay analysis using MTD-1A cells indicates that Necl-2 is assembled to the cell-cell adhesion sites at the very early stage together with the components of the nectin-afadin and E-cadherin-catenin units. After Necl-2 is assembled to the primordial cell-cell adhesion sites, it may be translocated from there to the extra-junctional region of the basolateral plasma membrane. Nectins are confined to AJs undercoated with F-actin bundles and are absent from the areas where Necl-2 localizes (5). Therefore, Necl-2 is likely to form homodimers at these areas lacking nectins. The mechanism of segregation of Necl-2 from nectin-3 at the plasma membrane is currently unknown, but it is of crucial importance for our understanding of how the membrane domains of epithelial cells are organized.

It has been shown that TSLC1 binds DAL-1 through a band 4.1-binding motif at the juxtamembrane region (18). We have shown here that Necl-2 does not bind afadin but directly binds Pals2. This binding is mediated through the C-terminal consensus motif of four aa of Necl-2 and the PDZ domain of Pals2. Thus, Necl-2 appears to bind both DAL-1 and Pals2. DAL-1 belongs to the band 4.1 family, connects TSLC1/Necl-2 to the actin cytoskeleton (18), and is known as a tumor suppressor (41). In contrast, Pals2 is a membrane-associated guanylate kinase family member and binds to Lin-7, of which the C. elegans homologue is implicated in the proper localization of the Let-23 protein, the homologue of mammalian epidermal growth factor receptor (42). Taken together, Necl-2 directly binds to Necl-1 and nectin-3 extracellularly, mediating cell adhesions, and also binds Pals2 intracellularly, mediating localizations of transmembrane proteins. Further studies would be necessary for our understanding of the physiological role of Necl-2, which regulates cell-cell adhesion and localization of transmembrane proteins in mammals.


    FOOTNOTES
 
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY351388 [GenBank] .

* The work at Osaka University was supported by grants-in-aid for Scientific Research and that for Cancer Research was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (2001, 2002). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

|| To whom correspondence should be addressed. Tel.: 81-6-6879-3410; Fax: 81-6-6879-3419; E-mail: ytakai{at}molbio.med.osaka-u.ac.jp.

1 The abbreviations used are: TJs, tight junctions; AJs, adherens junctions; DSs, desmosomes; F-actin, actin filament; aa, amino acid(s); Necl, nectin-like molecule; GST, glutathione S-transferase; MBP, maltose-binding protein; nectin-1-L cells, L cells stably expressing human nectin-1{alpha}; nectin-2-L cells, L cells stably expressing mouse nectin-2{alpha}; nectin-3-L cells, L cells stably expressing mouse nectin-3{alpha}; Necl-5-L cells, L cells stably expressing Necl-5; Necl-1-L cells, L cells stably expressing FLAG-Necl-1; non-tagged Necl-2-L cells, L cells stably expressing full-length Necl-2; Necl-2-L cells, L cells stably expressing FLAG-Necl-2; Necl-2-{Delta}C-L cells, L cells stably expressing the C-terminal four aa-deleted Necl-2; GST-Necl-2-CP, the cytoplasmic region of Necl-2 fused to GST; Ab, antibody; mAb, monoclonal Ab; pAb, polyclonal Ab; MDCK, Madin-Darby canine kidney; GFP, green fluorescent protein; JAM, junctional adhesion molecule; Necl-2-{Delta}EC, the transmembrane and cytoplasmic region of Necl-2; MBP-Pals2, full-length Pals2 fused to MBP; MBP-Pals2-PDZ, the PDZ domain of Pals2 fused to MBP; GST-Necl-2-CP{Delta}C, the C-terminal four-aa-deleted cytoplasmic region of Necl-2 fused to GST; HA, hemagglutinin. Back


    ACKNOWLEDGMENTS
 
We thank Dr. S. Tsukita (Kyoto University, Kyoto, Japan) for providing us with L and MTD-1A cells and Dr. B. Margolis (University of Michigan Medical Center, Ann Arbor, MI) for providing us with cDNA of Pals2. We thank Yoko Inoue and Akiko Hamaguchi (KAN Research Institute Inc.) for helpful assistance.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Tsukita, S., Furuse, M., and Itoh, M. (2001) Nat. Rev. Mol. Cell Biol. 2, 285–293[CrossRef][Medline] [Order article via Infotrieve]
  2. Takeichi, M. (1988) Development 102, 639–655[Abstract/Free Full Text]
  3. Gumbiner, B. M. (2000) J. Cell Biol. 148, 399–404[Abstract/Free Full Text]
  4. Garrod, D. R., Merritt, A. J., and Nie, Z. (2002) Curr. Opin. Cell Biol. 14, 537–545[CrossRef][Medline] [Order article via Infotrieve]
  5. Takai, Y., and Nakanishi, H. (2003) J. Cell Sci. 116, 17–27[Abstract/Free Full Text]
  6. Ikeda, W., Kakunaga, S., Itoh, S., Shingai, T., Takekuni, K., Satoh, K., Inoue, Y., Hamaguchi, A., Morimoto, K., Takeuchi, M., Imai, T., and Takai, Y. (2003) J. Biol. Chem. 278, 28167–28172[Abstract/Free Full Text]
  7. Fukuhara, H., Kuramochi, M., Nobukuni, T., Fukami, T., Saino, M., Maruyama, T., Nomura, S., Sekiya, T., and Murakami, Y. (2001) Oncogene 20, 5401–5407[CrossRef][Medline] [Order article via Infotrieve]
  8. Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E. T., and Sudhof, T. C. (2002) Science 297, 1525–1531[Abstract/Free Full Text]
  9. Gomyo, H., Arai, Y., Tanigami, A., Murakami, Y., Hattori, M., Hosoda, F., Arai, K., Aikawa, Y., Tsuda, H., Hirohashi, S., Asakawa, S., Shimizu, N., Soeda, E., Sakaki, Y., and Ohki, M. (1999) Genomics 62, 139–146[CrossRef][Medline] [Order article via Infotrieve]
  10. Urase, K., Soyama, A., Fujita, E., and Momoi, T. (2001) Neuroreport 12, 3217–3221[CrossRef][Medline] [Order article via Infotrieve]
  11. Wakayama, T., Ohashi, K., Mizuno, K., and Iseki, S. (2001) Mol. Reprod. Dev. 60, 158–164[CrossRef][Medline] [Order article via Infotrieve]
  12. Kuramochi, M., Fukuhara, H., Nobukuni, T., Kanbe, T., Maruyama, T., Ghosh, H. P., Pletcher, M., Isomura, M., Onizuka, M., Kitamura, T., Sekiya, T., Reeves, R. H., and Murakami, Y. (2001) Nat. Genet. 27, 427–430[CrossRef][Medline] [Order article via Infotrieve]
  13. Chadeneau, C., LeMoullac, B., and Denis, M. G. (1994) J. Biol. Chem. 269, 15601–15605[Abstract/Free Full Text]
  14. Chadeneau, C., LeCabellec, M., LeMoullac, B., Meflah, K., and Denis, M. G. (1996) Int. J. Cancer 68, 817–821[CrossRef][Medline] [Order article via Infotrieve]
  15. Mendelsohn, C. L., Wimmer, E., and Racaniello, V. R. (1989) Cell 56, 855–865[CrossRef][Medline] [Order article via Infotrieve]
  16. Koike, S., Horie, H., Ise, I., Okitsu, A., Yoshida, M., Iizuka, N., Takeuchi, K., Takegami, T., and Nomoto, A. (1990) EMBO J. 9, 3217–3224[Medline] [Order article via Infotrieve]
  17. Masuda, M., Yageta, M., Fukuhara, H., Kuramochi, M., Maruyama, T., Nomoto, A., and Murakami, Y. (2002) J. Biol. Chem. 277, 31014–31019[Abstract/Free Full Text]
  18. Yageta, M., Kuramochi, M., Masuda, M., Fukami, T., Fukuhara, H., Maruyama, T., Shibuya, M., and Murakami, Y. (2002) Cancer Res. 62, 5129–5133[Abstract/Free Full Text]
  19. Fukami, T., Satoh, H., Fujita, E., Maruyama, T., Fukuhara, H., Kuramochi, M., Takamoto, S., Momoi, T., and Murakami, Y. (2002) Gene 295, 7–12[CrossRef][Medline] [Order article via Infotrieve]
  20. Kamberov, E., Makarova, O., Roh, M., Liu, A., Karnak, D., Straight, S., and Margolis, B. (2000) J. Biol. Chem. 275, 11425–11431[Abstract/Free Full Text]
  21. Margolis, B., Borg, J. P., Straight, S., and Meyer, D. (1999) Kidney Int. 56, 1230–1237[CrossRef][Medline] [Order article via Infotrieve]
  22. Miyahara, M., Nakanishi, H., Takahashi, K., Satoh-Horikawa, K., Tachibana, K., and Takai, Y. (2000) J. Biol. Chem. 275, 613–618[Abstract/Free Full Text]
  23. Niwa, H., Burdon, T., Chambers, I., and Smith, A. (1998) Genes Dev. 12, 2048–2060[Abstract/Free Full Text]
  24. James, P., Halladay, J., and Craig, E. A. (1996) Genetics 144, 1425–1436[Abstract]
  25. Tachibana, K., Nakanishi, H., Mandai, K., Ozaki, K., Ikeda, W., Yamamoto, Y., Nagafuchi, A., Tsukita, S., and Takai, Y. (2000) J. Cell Biol. 150, 1161–1176[Abstract/Free Full Text]
  26. Sakisaka, T., Taniguchi, T., Nakanishi, H., Takahashi, K., Miyahara, M., Ikeda, W., Yokoyama, S., Peng, Y. F., Yamanishi, K., and Takai, Y. (2001) J. Virol. 75, 4734–4743[Abstract/Free Full Text]
  27. Takaesu, G., Kishida, S., Hiyama, A., Yamaguchi, K., Shibuya, H., Irie, K., Ninomiya-Tsuji, J., and Matsumoto, K. (2000) Mol. Cell 5, 649–658[CrossRef][Medline] [Order article via Infotrieve]
  28. Takahashi, K., Nakanishi, H., Miyahara, M., Mandai, K., Satoh, K., Satoh, A., Nishioka, H., Aoki, J., Nomoto, A., Mizoguchi, A., and Takai, Y. (1999) J. Cell Biol. 145, 539–549[Abstract/Free Full Text]
  29. Satoh-Horikawa, K., Nakanishi, H., Takahashi, K., Miyahara, M., Nishimura, M., Tachibana, K., Mizoguchi, A., and Takai, Y. (2000) J. Biol. Chem. 275, 10291–10299[Abstract/Free Full Text]
  30. Mandai, K., Nakanishi, H., Satoh, A., Obaishi, H., Wada, M., Nishioka, H., Itoh, M., Mizoguchi, A., Aoki, T., Fujimoto, T., Matsuda, Y., Tsukita, S., and Takai, Y. (1997) J. Cell Biol. 139, 517–528[Abstract/Free Full Text]
  31. Mizoguchi, A., Yano, Y., Hamaguchi, H., Yanagida, H., Ide, C., Zahraoui, A., Shirataki, H., Sasaki, T., and Takai, Y. (1994) Biochem. Biophys. Res. Commun. 202, 1235–1243[CrossRef][Medline] [Order article via Infotrieve]
  32. Laemmli, U. K. (1970) Nature 227, 680–685[CrossRef][Medline] [Order article via Infotrieve]
  33. Bradford, M. M. (1976) Anal. Biochem. 72, 248–254[CrossRef][Medline] [Order article via Infotrieve]
  34. Asakura, T., Nakanishi, H., Sakisaka, T., Takahashi, K., Mandai, K., Nishimura, M., Sasaki, T., and Takai, Y. (1999) Genes Cells 4, 573–581[Abstract]
  35. Yonemura, S., Itoh, M., Nagafuchi, A., and Tsukita, S. (1995) J. Cell Sci. 108, 127–142[Abstract]
  36. Ebnet, K., Suzuki, A., Horikoshi, Y., Hirose, T., Meyer Zu Brickwedde, M. K., Ohno, S., and Vestweber, D. (2001) EMBO J. 20, 3738–3748[CrossRef][Medline] [Order article via Infotrieve]
  37. Suzuki, A., Ishiyama, C., Hashiba, K., Shimizu, M., Ebnet, K., and Ohno, S. (2002) J. Cell Sci. 115, 3565–3573[Abstract/Free Full Text]
  38. Ando-Akatsuka, Y., Yonemura, S., Itoh, M., Furuse, M., and Tsukita, S. (1999) J. Cell Physiol. 179, 115–125[CrossRef][Medline] [Order article via Infotrieve]
  39. Tsukita, S., Nagafuchi, A., and Yonemura, S. (1992) Curr. Opin. Cell Biol. 4, 834–839[CrossRef][Medline] [Order article via Infotrieve]
  40. Gumbiner, B. M. (1996) Cell 84, 345–357[CrossRef][Medline] [Order article via Infotrieve]
  41. Tran, Y. K., Bogler, O., Gorse, K. M., Wieland, I., Green, M. R., and Newsham, I. F. (1999) Cancer Res. 59, 35–43[Abstract/Free Full Text]
  42. Kaech, S. M., Whitfield, C. W., and Kim, S. K. (1998) Cell 94, 761–771[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
F. Hollins, D. Kaur, W. Yang, G. Cruse, R. Saunders, A. Sutcliffe, P. Berger, A. Ito, C. E. Brightling, and P. Bradding
Human Airway Smooth Muscle Promotes Human Lung Mast Cell Survival, Proliferation, and Constitutive Activation: Cooperative Roles for CADM1, Stem Cell Factor, and IL-6
J. Immunol., August 15, 2008; 181(4): 2772 - 2780.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
J.-S. Kang, G.-U. Bae, M.-J. Yi, Y.-J. Yang, J.-E. Oh, G. Takaesu, Y. T. Zhou, B. C. Low, and R. S. Krauss
A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38{alpha}/{beta} MAPK activity and myogenic differentiation
J. Cell Biol., August 11, 2008; 182(3): 497 - 507.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. D. Mruk, B. Silvestrini, and C. Y. Cheng
Anchoring Junctions As Drug Targets: Role in Contraceptive Development
Pharmacol. Rev., June 1, 2008; 60(2): 146 - 180.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Fujita, Y. Tanabe, T. Hirose, M. Aurrand-Lions, T. Kasahara, B. A. Imhof, S. Ohno, and T. Momoi
Loss of Partitioning-Defective-3/Isotype-Specific Interacting Protein (Par-3/ASIP) in the Elongating Spermatid of RA175 (IGSF4A/SynCAM)-Deficient Mice
Am. J. Pathol., December 1, 2007; 171(6): 1800 - 1810.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. I. Fogel, M. R. Akins, A. J. Krupp, M. Stagi, V. Stein, and T. Biederer
SynCAMs Organize Synapses through Heterophilic Adhesion
J. Neurosci., November 14, 2007; 27(46): 12516 - 12530.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
P. Maurel, S. Einheber, J. Galinska, P. Thaker, I. Lam, M. B. Rubin, S. S. Scherer, Y. Murakami, D. H. Gutmann, and J. L. Salzer
Nectin-like proteins mediate axon Schwann cell interactions along the internode and are essential for myelination
J. Cell Biol., August 27, 2007; 178(5): 861 - 874.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. Wakayama, Y. Sai, A. Ito, Y. Kato, M. Kurobo, Y. Murakami, E. Nakashima, A. Tsuji, Y. Kitamura, and S. Iseki
Heterophilic Binding of the Adhesion Molecules Poliovirus Receptor and Immunoglobulin Superfamily 4A in the Interaction Between Mouse Spermatogenic and Sertoli Cells
Biol Reprod, June 1, 2007; 76(6): 1081 - 1090.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
V. M. Wu, M. H. Yu, R. Paik, S. Banerjee, Z. Liang, S. M. Paul, M. A. Bhat, and G. J. Beitel
Drosophila Varicose, a member of a new subgroup of basolateral MAGUKs, is required for septate junctions and tracheal morphogenesis
Development, March 1, 2007; 134(5): 999 - 1009.
[Abstract] [Full Text] [PDF]